A medical-record study found different weight-loss outcomes among people taking semaglutide or tirzepatide (n = 135,349) [1]. The guide to how long GLP-1 effects take explains why the timing of measurement matters. The records study grouped people by measured weight change.
What might explain differences?
The study found associations with treatment formulation and patient characteristics. Dose, the reason for prescribing and differences between patient groups can all affect comparisons from records. Researchers did not assign treatments at random.
Does response always mean losing weight?
In a separate clinic cohort, researchers followed adults with type 2 diabetes on stable metformin-based regimens (n = 166). About 53% improved on their blood-sugar measure while falling short of the study's fat-mass threshold [2]. Our guide to changes in body composition on GLP-1 treatment explains why weight and tissue measures differ. The clinic result pooled several treatment types.